Gene · 573
Papers2,074
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,074
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HER-2 ultra-low breast cancer: exploring the clinicopathological features and prognosis in a retrospective study. | Front Oncol | 2023 | 37664018 | PubTator, text mining | PubMed |
| Role of long non-coding RNAs in cancer: From subcellular localization to nanoparticle-mediated targeted regulation. | Mol Ther Nucleic Acids | 2023 | 37655045 | PubTator, text mining | PubMed |
| Development and Validation of a New BAG-1L-Specific Antibody to Quantify BAG-1L Protein Expression in Advanced Prostate Cancer. | Lab Invest | 2023 | 37652207 | PubTator, text mining | PubMed |
| Effects of Adding Chitosan on Drug Entrapment Efficiency and Release Duration for Paclitaxel-Loaded Hydroxyapatite-Gelatin Composite Microspheres. | Pharmaceutics | 2023 | 37631239 | PubTator, text mining | PubMed |
| Omics Technologies Improving Breast Cancer Research and Diagnostics. | Int J Mol Sci | 2023 | 37628869 | PubTator, text mining | PubMed |
| Uncovering Novel Roles of miR-122 in the Pathophysiology of the Liver: Potential Interaction with NRF1 and E2F4 Signaling. | Cancers (Basel) | 2023 | 37627157 | PubTator, text mining | PubMed |
| First-line osimertinib for patients with EGFR-mutated advanced non-small cell lung cancer: efficacy and safety during the COVID-19 pandemic. | Transl Lung Cancer Res | 2023 | 37577326 | PubTator, text mining | PubMed |
| Analysis of Under-Diagnosed Malignancy during Fine Needle Aspiration Cytology of Lymphadenopathies. | Int J Mol Sci | 2023 | 37569769 | PubTator, text mining | PubMed |
| Reactive oxygen species mediated apoptotic death of colon cancer cells: therapeutic potential of plant derived alkaloids. | Front Endocrinol (Lausanne) | 2023 | 37560308 | PubTator, text mining | PubMed |
| The potential development of drug resistance in rheumatoid arthritis patients identified with p53 mutations. | Genes Dis | 2023 | 37554177 | PubTator, text mining | PubMed |
| Invasive Breast Cancer with HER2 ≥4.0 and <6.0: Risk Classification and Molecular Typing by a 21-Gene Expression Assay and MammaPrint Plus BluePrint Testing. | Breast Cancer (Dove Med Press) | 2023 | 37554155 | PubTator, text mining | PubMed |
| Association of PD-L1 tumor proportion score ≥20% with early resistance to osimertinib in patients with EGFR-mutated NSCLC. | Cancer Med | 2023 | 37548381 | PubTator, text mining | PubMed |
| Application of G-quadruplex targets in gastrointestinal cancers: Advancements, challenges and prospects. | World J Gastrointest Oncol | 2023 | 37546556 | PubTator, text mining | PubMed |
| A comprehensive analysis of biomarkers associated with synovitis and chondrocyte apoptosis in osteoarthritis. | Front Immunol | 2023 | 37545537 | PubTator, text mining | PubMed |
| Valosin containing protein (VCP): initiator, modifier, and potential drug target for neurodegenerative diseases. | Mol Neurodegener | 2023 | 37545006 | PubTator, text mining | PubMed |
| Identification of an Imidazopyridine-based Compound as an Oral Selective Estrogen Receptor Degrader for Breast Cancer Therapy. | Cancer Res Commun | 2023 | 37520743 | PubTator, text mining | PubMed |
| Nanoparticle-Based Antioxidants in Stress Signaling and Programmed Cell Death in Breast Cancer Treatment. | Molecules | 2023 | 37513179 | PubTator, text mining | PubMed |
| Herpes Simplex Virus, Human Papillomavirus, and Cervical Cancer: Overview, Relationship, and Treatment Implications. | Cancers (Basel) | 2023 | 37509353 | PubTator, text mining | PubMed |
| Fibrous PVA Matrix Containing Strontium-Substituted Hydroxyapatite Nanoparticles from Golden Apple Snail (Pomacea canaliculata L.) Shells for Bone Tissue Engineering. | Bioengineering (Basel) | 2023 | 37508870 | PubTator, text mining | PubMed |
| High Boron Content Enhances Bioactive Glass Biodegradation. | J Funct Biomater | 2023 | 37504859 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/573/papers?page=6